Search Results

Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations

Authors: Widhalm, K.; Dirisamer, A.; Lindemayr, A.; Kostner, G.

Source: Journal of Inherited Metabolic Disease, Volume 30, Number 2, April 2007 , pp. 239-247(9)

Publisher: Springer

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

Authors: Burnett, John R; Watts, Gerald F

Source: Expert Opinion on Therapeutic Targets, Volume 11, Number 2, February 2007 , pp. 181-189(9)

Publisher: Informa Healthcare

Gene therapy for lipoprotein disorders

Authors: Broedl, Uli C; Rader, Daniel J

Source: Expert Opinion on Biological Therapy, Volume 5, Number 8, 1 August 2005 , pp. 1029-1038(10)

Publisher: Informa Healthcare

Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: Response to liver transplantation

Authors: Mignon Moyle; Bruce Tate

Source: Australasian Journal of Dermatology, Volume 45, Number 4, November 2004 , pp. 226-228(3)

Publisher: Blackwell Publishing

Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment

Authors: S. Lind; A. G. Olsson; M. Eriksson; M. Rudling; G. Eggertsen; B. Angelin

Source: Journal of Internal Medicine, Volume 256, Number 5, November 2004 , pp. 406-412(7)

Publisher: Blackwell Publishing

Homozygous familial hypercholesterolaemia: development of xanthogranuloma in a boy at puberty under long-term low-density lipoprotein apheresis and drug therapy

Authors: Saito M.; Tada Y.; Harada-Shiba M.; Yamamoto A.; Kusakabe N.; Yokogawa M.; Kodama H.; Asada H.; Miyagawa S.

Source: British Journal of Dermatology, Volume 149, Number 6, December 2003 , pp. 1302-1303(2)

Publisher: Blackwell Publishing

Pinpoint skin lesions in a familial hypercholesterolaemia homozygote

Authors: HJ Milionis; GA Miltiadous; M Cariolou; MS Elisaf

Source: Acta Paediatrica, Volume 92, Number 9, September 2003 , pp. 1109-1110(2)

Publisher: Informa Healthcare

LDL apheresis

Author: Thompson G.R.

Source: Atherosclerosis, Volume 167, Number 1, March 2003 , pp. 1-13(13)

Publisher: Elsevier

Ezetimibe

Authors: Darkes M.J.M.; Poole R.M.; Goa K.L.

Source: American Journal of Cardiovascular Drugs, Volume 3, Number 1, 2003 , pp. 67-76(10)

Publisher: Adis International

Effect of rosuvastatin on LDL-cholesterol, mevalonic acid and other lipid measurements in patients with homozygous familial hypercholesterolaemia - D. Marais¹, F. Raal², E. Stein³, D. Rader⁴, K. Smith⁵, J. Blasetto⁶, W. Wilpshaar^{5 1}Cape Heart Centre, Cape Town; ²Johannesburg Hospital, Johannesburg, South Africa; ³Medical Research Laboratories, Highland Heights, KY; ⁴University of Pennsylvania, Philadelphia, PA, USA; ⁵AstraZeneca, Macclesfield, Cheshire, UK; ⁶AstraZeneca, Wayne, PA, USA

Source: Atherosclerosis, Supplements, Volume 3, Number 2, October 2002 , pp. 159-159(1)

Publisher: Elsevier

LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia

Authors: Brorholt-Petersen J.; Jensen H.; Jensen J.; Refsgaard J.; Christiansen T.; Hansen L.; Gregersen N.; Faergeman O.

Source: Clinical Genetics, Volume 61, Number 6, June 2002 , pp. 408-415(8)

Publisher: Blackwell Publishing

Rosuvastatin

Authors: Carswell C.I.; Plosker G.L.; Jarvis B.

Source: Drugs, Volume 62, Number 14, 2002 , pp. 2075-2085(11)

Publisher: Adis International

Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia

Authors: Gaffney D.; Forster L.; Caslake M.J.; Bedford D.; Stewart J.P.; Stewart G.; Wieringa G.; Dominiczak M.; Miller J.P.; Packard C.J.

Source: Atherosclerosis, Volume 162, Number 1, May 2002 , pp. 33-43(11)

Publisher: Elsevier

Low-density lipoprotein apheresis in a patient aged 3.5 years

Authors: Stefanutti C; Di Giacomo S; Vivenzio A; Colloridi V; Bosco G; Berni A; Rabbone I; Cerutti F; Bertolini S

Source: Acta Paediatrica, Volume 90, Number 6, 1 June 2001 , pp. 694-701(8)

Publisher: Informa Healthcare

Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia

Authors: Miltiadous G.; Tsimihodimos V.; Bairaktari E.; Elisaf M.

Source: Atherosclerosis, Volume 157, Number 1, July 2001 , pp. 255-256(2)

Publisher: Elsevier

Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia

Author: Meier, Pascal

Source: Nephrology Dialysis Transplantation, Volume 15, Number 5, May 2000 , pp. 738-740(3)

Publisher: Oxford University Press

Coronary revascularization in a seven-year-old boy with homozygous familial hypercholesterolaemia

Authors: Ersoy Ü; Güvener M

Source: Acta Paediatrica, Volume 89, Number 12, 1 December 2000 , pp. 1501-1502(2)

Publisher: Informa Healthcare

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

Authors: Raal F.J.; Pappu A.S.; Illingworth D.R.; Pilcher G.J.; Marais A.D.; Firth J.C.; Kotze M.J.; Heinonen T.M.; Black D.M.

Source: Atherosclerosis, Volume 150, Number 2, June 2000 , pp. 421-428(8)

Publisher: Elsevier

Cell adhesion molecules - can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia?

Authors: Paiker J.E.; Raal F.J.; Veller M.; von Arb M.; Chetty N.; Naran N.H.

Source: Clinica Chimica Acta, Volume 293, Number 1, March 2000 , pp. 105-113(9)

Publisher: Elsevier

Inheritance of two different alleles of the low-density lipoprotein (LDL)-receptor gene carrying the recurrent Pro664Leu mutation in a patient with homozygous familial hypercholesterolaemia

Authors: Bourbon, Mafalda; Fowler, A. Michelle; Sun, Xi-Ming; Soutar, Anne K.

Source: Clinical Genetics, Volume 56, Number 3, September 1999 , pp. 225-231(7)

Publisher: Blackwell Publishing